Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives

References

• ByamJRenzJMillisJMLiver transplantation for hepatocellular carcinomaHepatobiliary Surg Nutr201321223024570911
   PubMedGoogle Scholar
• Center for Disease Control and Prevention (CDC) hepatocellular carcinoma – United States 2001–2006MMWR Morb Mortal Wkly Rep2010591751752020448528
   PubMedGoogle Scholar
• BaloghJVictorDAshamEHHepatocellular carcinoma: a reviewJ Hepatocell Carcinoma20163415327785449
   PubMed Web of Science ®Google Scholar
• NiuLLiuLYangSRenJLaiPBSChenGGNew insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategiesBiochim Biophys Acta186820172564570
   Google Scholar
• BruixJQinSMerlePRegorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialLancet201738910064566627932229
   PubMed Web of Science ®Google Scholar
• CascellaMBimonteSMuzioMRSchiavoneVCuomoAThe efficacy of epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practiceInfect Agent Cancer20171213628642806
   PubMed Web of Science ®Google Scholar
• BimonteSLeongitoMBarbieriAInhibitory effect of (-)-epi-gallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growthInfect Agent Cancer20151012226225138
   PubMed Web of Science ®Google Scholar
• DarweishMMEbrahimMAAl-GayyarMMAbbasAAnticancer activity of EGCG against HCCJ Pharm Pharmacol2014661032104524611903
   PubMed Web of Science ®Google Scholar
• ZhangHCaoDCuiWJiMQianXZhongLMolecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallateFree Radic Biol Med201049122010201820951799
   PubMed Web of Science ®Google Scholar
• ZhouLEliasRJAntioxidant and pro-oxidant activity of (-)-epigal-locatechin-3-gallate in food emulsions: Influence of pH and phenolic concentrationFood Chem20131382–31503150923411273
   PubMed Web of Science ®Google Scholar
• FarhanMRizviANaseemIHadiSMAhmadATargeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallateTumor Biol2015361188618867
   PubMedGoogle Scholar
• FarhanMKhanHYOvesMCancer therapy by catechins involves redox cycling of copper ions and generation of reactive oxygen speciesToxins2016823726861392
   PubMed Web of Science ®Google Scholar
• MacleodMRO’CollinsTHowellsDWDonnanGAStroke pooling of animal experimental data reveals influence of study design and publication bias20043512031208
   Google Scholar
• BimonteSCascellaMSchiavoneVMehrabi-KermaniFCuomoAThe roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectivesDrug Des Devel Ther20171127372742
   PubMed Web of Science ®Google Scholar
• KhanHYZubairHUllahMFAhmadAHadiSMOral administration of copper to rats leads to increased lymphocyte cellular DNA degradation by dietary polyphenols: implications for a cancer preventive mechanismBiometals20112461169117821717118
   PubMed Web of Science ®Google Scholar
• GupteAMumperRJElevated copper and oxidative stress in cancer cells as a target for cancer treatmentCancer Treat Rev2009351324618774652
   PubMed Web of Science ®Google Scholar
• LambertJDLeeMJLuHEpigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to miceJ Nutr2003133124172417714652367
   PubMed Web of Science ®Google Scholar
• LuHMengXYangCSEnzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallateDrug Metab Dispos200331557257912695345
   PubMed Web of Science ®Google Scholar
• LiuABTaoSLeeMJEffects of gut microbiota and time of treatment on tissue levels of green tea polyphenols in miceBioFactors2018444348360
   Web of Science ®Google Scholar
• ChenCLiuQLiuLHuYYFengQPotential biological effects of (-)-epigallocatechin-3-gallate on the treatment of nonalcoholic fatty liver diseaseMol Nutr Food Res20186211700483
   PubMed Web of Science ®Google Scholar
• LeeMJMaliakalPChenLPharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variabilityCancer Epidemiol Biomark Prev20021110251032
   PubMed Web of Science ®Google Scholar
• AltlandKSchreinerRHunsteinWOf green tea, black pepper, and amyloidoses2010 Available from: http://www.ukgm.de/ugm_2/deu/ugi_hum/EGCG_Piperin_engl.pdfAccessed July 13, 2011
   Google Scholar
• AugerCMullenWHaraYCrozierABioavailability of poly-phenon E flavan-3-ols in humans with an ileostomyJ Nutr200813881535S1542S18641203
   PubMed Web of Science ®Google Scholar
• StalmachATroufflardSSerafiniMCrozierAAbsorption, metabolism and excretion of Choladi green tea flavan-3-ols by humansMol Nutr Food Res200953Suppl 1S44S5318979506
   PubMed Web of Science ®Google Scholar
• RoowiSStalmachAMullenWLeanMEEdwardsCACrozierAGreen tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humansJ Agric Food Chem20105821296130420041649
   PubMed Web of Science ®Google Scholar
• MerelesDHunsteinWEpigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?Int J Mol Sci20111295592560322016611
   PubMed Web of Science ®Google Scholar
• LiNTaylorLSMauerLJDegradation kinetics of catechins in green tea powder: effects of temperature and relative humidityJ Agric Food Chem201159116082609021495730
   PubMed Web of Science ®Google Scholar
• IshiiTIchikawaTMinodaKHuman serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilizationBiosci Biotechnol Biochem201175110010621228463
   PubMed Web of Science ®Google Scholar
• HunsteinWAL-amyloidosis and epigallocatechin-3-gallate: 4 years and 5 months later2011 Available from: http://www.hunstein-egcg.deAccessed July 13, 2011
   Google Scholar
• PetersCMGreenRJJanleEMFerruzziMGFormulation with ascorbic acid and sucrose modulates catechin bioavailability from green teaFood Res Int20104319510220161530
   PubMed Web of Science ®Google Scholar
• GiuntaBHouHZhuYFish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 miceNeurosci Lett2010471313413820096749
   PubMed Web of Science ®Google Scholar
• DubeANicolazzoJALarsonIChitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallateEur J Pharm Sci201041221922520600878
   PubMed Web of Science ®Google Scholar
• HuBTingYYangXTangWZengXHuangQNanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailabilityChem Commun2012481824212423
   PubMed Web of Science ®Google Scholar
• VyasSSharmaMSharmaPDSinghTVDesignSTVDesign, semi-synthesis, and evaluation of O-acyl derivatives of (-)-epigallocatechin-3-gallate as antitumor agentsJ Agric Food Chem200755156319632417608429
   PubMed Web of Science ®Google Scholar
• TanakaHMiyoshiHChuangYCAndoYTakahashiTSolid-phase synthesis of epigallocatechin gallate derivativesAngew Chem Int Ed2007463159345937
   PubMed Web of Science ®Google Scholar
• NishidaHOmoriMFukutomiYInhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cellsJpn J Cancer Res19948532212257514585
   PubMedGoogle Scholar
• ZhangGMiuraYYagasakiKSuppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activityCancer Lett2000159216917310996728
   PubMed Web of Science ®Google Scholar
• UesatoSKitagawaYKamishimotoMKumagaiAHoriHNagasawaHInhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cellsCancer Lett20011701414411448533
   PubMed Web of Science ®Google Scholar
• ParkHJShinDHChungWJEpigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cellsLife Sci200678242826283216445947
   PubMed Web of Science ®Google Scholar
• NishikawaTNakajimaTMoriguchiMA green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of BCL2 family proteinsJ Hepatol20064461074108216481065
   PubMed Web of Science ®Google Scholar
• ZhangYOwusuLDuanWAnti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cellsInt J Mol Med201332495996423863984
   PubMed Web of Science ®Google Scholar
• ZhangQTangXLuQZhangZRaoJLeADGreen tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cellsMol Cancer Ther2006551227123816731755
   PubMed Web of Science ®Google Scholar
• LeeSJLeeKWHurHJChunJYKimSYLeeHJPhenolic phytochemicals derived from red pine (Pinus densiflora) inhibit the invasion and migration of SK-HEP-1 human hepatocellular carcinoma cellsAnn N Y Acad Sci20071095153654417404067
   PubMed Web of Science ®Google Scholar
• LeeSIKimHJBooYCEffect of green tea and (-)-epigallocatechin gallate on ethanol-induced toxicity in HepG2 cellsPhytother Res200822566967418350509
   PubMed Web of Science ®Google Scholar
• ShimizuMShirakamiYSakaiHEGCG inhibits activation of the insulin-like growth factor (IGF)/IGF1 receptor axis in human hepatocellular carcinoma cellsCancer Lett20082621101818164805
   PubMed Web of Science ®Google Scholar
• ChenLYeHLZhangGAutophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cellsPLoS One201491e8577124465696
   PubMed Web of Science ®Google Scholar
• KaufmannRHenkleinPHenkleinPSettmacherUGreen tea poly-phenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activationOncol Rep20092151261126719360302
   PubMed Web of Science ®Google Scholar
• ShirakamiYShimizuMAdachiS(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axisCancer Sci2009100101957196219558547
   PubMed Web of Science ®Google Scholar
• HuangCHTsaiSJWangYJPanMHKaoJYWayTDEGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cellsMol Nutr Food Res20095391156116519662644
   PubMed Web of Science ®Google Scholar
• TongJLNieFRanZHEpigallocatechin gallate induces apoptosis in human hepatocellular carcinoma HepG2 cells via TGF/Smad signaling pathwayZhonghua Zhong Liu Za Zhi2009319646650 Chinese20021857
   PubMedGoogle Scholar
• LiangGTangALinXGreen tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancerInt J Oncol201037111112320514403
   PubMed Web of Science ®Google Scholar
• HuangWDingLHuangQCarbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinomaHepatology201052270371420683966
   PubMed Web of Science ®Google Scholar
• YangXWWangXLCaoLQGreen tea polyphenol epigallocatechin-3-gallate enhances 5-fluorouracil-induced cell growth inhibition of hepatocellular carcinoma cellsHepatol Res201242549450122221825
   PubMed Web of Science ®Google Scholar
• JinJChangYWeiWProstanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitroActa Pharmacologica Sinica201233570170922555372
   PubMed Web of Science ®Google Scholar
• HashimotoONakamuraANakamuraTMethylated-(3″)-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesisNutr Cancer201466472873524033329
   PubMed Web of Science ®Google Scholar
• WangYRenXDengCMechanism of the inhibition of the STAT3 signaling pathway by EGCGOncol Rep20133062691269624065300
   PubMed Web of Science ®Google Scholar
• ShenXZhangYFengYEpigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the Akt pathwayInt J Oncol201444379179624402647
   PubMed Web of Science ®Google Scholar
• ZhangYDuanWOwusuLWuDXinYEpigallocatechin-3-gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not non-cancerous liver cellsInt J Mol Med201535111712425370579
   PubMed Web of Science ®Google Scholar
• ZapfMAKothariANWeberCEGreen tea component epigal-locatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinomaSurgery201515841039104826189955
   PubMed Web of Science ®Google Scholar
• WubetuGYShimadaMMorineYEpigallocatechin gallate hinders human hepatoma and colon cancer sphere formationJ Gastroenterol Hepatol201631125626426241688
   PubMed Web of Science ®Google Scholar
• LiSWuLFengJIn vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activitySci Rep2016612847927349173
   PubMed Web of Science ®Google Scholar
• SatonakaHIshidaKTakaiM(-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and Mek/ERK Signaling PathwaysAnticancer Res201737116071607729061787
   PubMed Web of Science ®Google Scholar
• ZhaoLLiuSXuJA new molecular mechanism underlying the EGCG-mediated autophagic modulation of AFP in HepG2 cellsCell Death Dis2017811e316029095434
   PubMed Web of Science ®Google Scholar
• CascellaMPalmaGBarbieriARole of Nigella sativa and its constituent thymoquinone on chemotherapy-induced nephrotoxicity: Evidences from experimental animal studiesNutrients201796625
   PubMed Web of Science ®Google Scholar
• CascellaMChemotherapy-induced peripheral neuropathy: limitations in current prophylactic strategies and directions for future researchCurr Med Res Opin201733698198428097895
   PubMed Web of Science ®Google Scholar
• CascellaMPreoperative cardiac evaluation and anesthetic considerations for cancer patients who underwent chemotherapyTrends Anaesth Crit Care201714918
   Web of Science ®Google Scholar
• Jimenez-SaenzMMartinez-SanchezMCAcute hepatitis associated with the use of green tea infusionsJ Hepatol200644361661716427718
   PubMed Web of Science ®Google Scholar
• LambertJDKennettMJSangSReuhlKRJuJYangCSHepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in miceFood Chem Toxicol201048140941619883714
   PubMed Web of Science ®Google Scholar
• JamesKDKennettMJLambertJDPotential role of the mitochondria as a target for the hepatotoxic effects of (-)-epigallocatechin-3-gallate in miceFood Chem Toxicol201811130230929175576
   PubMed Web of Science ®Google Scholar
• GarcíaERGutierrezEAFcsadeMeloNovaesRDGonçalvesRVFlavonoids effects on hepatocellular carcinoma in murine models: a systematic reviewEvid Based Complement Alternat Med20182018632897029681978
   PubMed Web of Science ®Google Scholar